Literature DB >> 28222667

Curcumin inhibits cancer progression through regulating expression of microRNAs.

Siying Zhou1,2, Sijie Zhang3, Hongyu Shen2,4, Wei Chen5, Hanzi Xu1,6, Xiu Chen2,4, Dawei Sun2, Shanliang Zhong7, Jianhua Zhao7, Jinhai Tang1,2,8.   

Abstract

Curcumin, a major yellow pigment and spice in turmeric and curry, is a powerful anti-cancer agent. The anti-tumor activities of curcumin include inhibition of tumor proliferation, angiogenesis, invasion and metastasis, induction of tumor apoptosis, increase of chemotherapy sensitivity, and regulation of cell cycle and cancer stem cell, indicating that curcumin maybe a strong therapeutic potential through modulating various cancer progression. It has been reported that microRNAs as small noncoding RNA molecules are related to cancer progression, which can be regulated by curcumin. Dysregulated microRNAs play vital roles in tumor biology via regulating expressions of target genes and then influencing multiple cancer-related signaling pathways. In this review, we focused on the inhibition effect of curcumin on various cancer progression by regulating expression of multiple microRNAs. Curcumin-induced dysregulation of microRNAs may activate or inactivate a set of signaling pathways, such as Akt, Bcl-2, PTEN, p53, Notch, and Erbb signaling pathways. A better understanding of the relation between curcumin and microRNAs may provide a potential therapeutic target for various cancers.

Entities:  

Keywords:  Curcumin; cancer; microRNA; signaling pathway; therapy

Mesh:

Substances:

Year:  2017        PMID: 28222667     DOI: 10.1177/1010428317691680

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  16 in total

Review 1.  Medicinal Foods for Functional GI Disorders.

Authors:  Brent W Acker; Brooks D Cash
Journal:  Curr Gastroenterol Rep       Date:  2017-11-13

2.  Induction of Apoptosis and Regulation of MicroRNA Expression by (2E,6E)-2,6-bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) Treatment on MCF-7 Breast Cancer Cells.

Authors:  Swee Keong Yeap; Norlaily Mohd Ali; Muhammad Nadeem Akhtar; Nursyamirah Abd Razak; Zhi Xiong Chong; Wan Yong Ho; Lily Boo; Seema Zareen; Tonni Agustiono Kurniawan; Ram Avtar; Stephanie Y L Ng; Alan Han Kiat Ong; Noorjahan Banu Alitheen
Journal:  Molecules       Date:  2021-02-26       Impact factor: 4.411

3.  Curcumin Suppresses the Colon Cancer Proliferation by Inhibiting Wnt/β-Catenin Pathways via miR-130a.

Authors:  Huiqiang Dou; Renhui Shen; Jianxin Tao; Longchang Huang; Haoze Shi; Hang Chen; Yixin Wang; Tong Wang
Journal:  Front Pharmacol       Date:  2017-11-24       Impact factor: 5.810

4.  Concentration- Dependent Effects of Curcumin on 5-Fluorouracil Efficacy in Bladder Cancer Cells

Authors:  Noushin Afsharmoghadam; Zahra Haghighatian; Hamid Mazdak; Nooshin Mirkheshti; Razieh Mehrabi Koushki; Sayyed Ali Alavi
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-28

5.  Growth-Inhibitory Effect of Chitosan-Coated Liposomes Encapsulating Curcumin on MCF-7 Breast Cancer Cells.

Authors:  Mahmoud Hasan; Kamil Elkhoury; Nabila Belhaj; Cyril Kahn; Ali Tamayol; Muriel Barberi-Heyob; Elmira Arab-Tehrany; Michel Linder
Journal:  Mar Drugs       Date:  2020-04-17       Impact factor: 5.118

6.  miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth.

Authors:  Nagindra Prashad
Journal:  Oncotarget       Date:  2018-09-04

7.  Curcumin Inhibits LIN-28A through the Activation of miRNA-98 in the Lung Cancer Cell Line A549.

Authors:  Wei-Lun Liu; Jia-Ming Chang; Inn-Wen Chong; Yi-Li Hung; Yung-Hsiang Chen; Wen-Tsung Huang; Hsuan-Fu Kuo; Chong-Chao Hsieh; Po-Len Liu
Journal:  Molecules       Date:  2017-06-03       Impact factor: 4.411

8.  Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice.

Authors:  Mingxiang Chang; Meimei Wu; Hanmin Li
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

9.  SWATH-MS based quantitative proteomics analysis reveals that curcumin alters the metabolic enzyme profile of CML cells by affecting the activity of miR-22/IPO7/HIF-1α axis.

Authors:  Francesca Monteleone; Simona Taverna; Riccardo Alessandro; Simona Fontana
Journal:  J Exp Clin Cancer Res       Date:  2018-07-25

10.  Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway.

Authors:  Xiaofeng Zhu; Ronghua Zhu
Journal:  Onco Targets Ther       Date:  2018-06-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.